Skip to content

A Prospective, Randomized, Single-blind Controlled Study of Autogenous Bone Marrow Enriched Technique for Adolescent Idiopathic Scoliosis

A Prospective, Randomized, Single-blind Controlled Study of Autogenous Bone Marrow Enriched Technique for Adolescent Idiopathic Scoliosis

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-14004948
Enrollment
Unknown
Registered
2014-06-18
Start date
2014-07-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adolescent Idiopathic Scoliosis

Interventions

A:Enriched Allogeneic Bone
B:Allogeneic Bone

Sponsors

Department of Orthopaedics, Southwest Hospital, the Third Military Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
10 Years to 20 Years

Inclusion criteria

Inclusion criteria: 1. Patients with scoliosis and spinal deformity (Cobb angle more than 45 degree, Lenke grade I-III) with serious impact on the beauty but with good spinal flexibility, or those with deformity progressing rapidly in a short time, sharply limited pulmonary function due to thoracic deformity and affected daily activity; 2. Age 10-20, all genders; 3. Patients without any contraindication to bone marrow extraction, such as blood system diseases (e.g., coagulation disturbance), infection at venipuncture sites, serious immunosuppression or allergic constitution.

Exclusion criteria

Exclusion criteria: 1. Age: younger than 10 or older than 20; 2. Patients with spinal stiffness complicated with razor-like back, with rib resection required and Lenke grade IV-VI; 3. Patients with operative contraindications caused by other accompanying diseases, such as serious respiratory, cardia-cerebrovascular, digestive, endocrine and urinary diseases; 4. Psychopaths, pregnant women, and those with bad addictions (e.g., drugs and alcohol); 5. Patients involved in other trials simultaneously or just finished other trials; 6. Patients with contraindications to bone marrow extraction, such as blood system diseases (e.g., coagulation disturbance), infection at venipuncture sites, serious immunosuppression and allergic constitution.

Design outcomes

Primary

MeasureTime frame
Visual Analog Scale;Oswestry Disability Index;RS30 scoliosis scale;Coronal and sagittal parameters;Percentage of bone fusion;Osteogenic quality scale;Evaluation and calculation of osteogenesis volume;Bone fusion tim;

Secondary

MeasureTime frame
Lenke classification;Operation time;Volume of bleeding in surgery;Postoperative hospital stay;

Contacts

Public ContactTianyong Hou
tianyonghou@126.com+86 023 65340297

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026